Viridian Therapeutics, Inc.\DE (VRDN) Preferred Dividend Payments (2016 - 2017)
Viridian Therapeutics, Inc.\DE (VRDN) posted quarterly Preferred Dividend Payments of $5000.0 for Q1 2017, up 141.67% year-over-year from $2069.0 in Q1 2016, and down 58.33% quarter-over-quarter from $12000.0 in Q4 2016.
Powered by 
Analysis
Viridian Therapeutics, Inc.\DE (VRDN) Preferred Dividend Payments (2016 - 2017) Analysis & Trends
Viridian Therapeutics, Inc.\DE's Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $5000.0 for Q1 2017.
- In Q1 2017, Preferred Dividend Payments rose 141.67% year-over-year to $5000.0; the TTM figure through Dec 2017 stood at $5000.0 (down 80.0% YoY), while the FY2017 annual figure was $5000.0, down 89.8% from the prior year.
- Preferred Dividend Payments for Q1 2017 stood at $5000.0, down from $12000.0 in the prior quarter.
- The five-year high for Preferred Dividend Payments was $13000.0 in Q3 2016, with the low at -$12000.0 in Q1 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Viridian Therapeutics, Inc.\DE | 2.42 Bn | 2.42 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2017 | 5,000.00 |
| Dec 31, 2016 | 12,000.00 |
| Sep 30, 2016 | 13,000.00 |
| Jun 30, 2016 | 12,000.00 |
| Mar 31, 2016 | -12,000.00 |